Aldeyra Therapeutics
ALDX
#10236
Rank
S$65.4 M
Marketcap
S$1.08
Share price
16.39%
Change (1 day)
-83.27%
Change (1 year)

Earnings for Aldeyra Therapeutics (ALDX)

Earnings in 2026 (TTM): -S$27.88 Million

According to Aldeyra Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$41.21 Million, an increase over its 2024 earnings that were of -S$69.57 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aldeyra Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$27.88 Million-32.34%
2025 -S$41.21 Million-40.77%
2024 -S$69.57 Million52.03%
2023 -S$45.76 Million-41.21%
2022 -S$77.83 Million7.67%
2021 -S$72.29 Million55.1%
2020 -S$46.61 Million-41.29%
2019 -S$79.38 Million58.81%
2018 -S$49.99 Million74.32%
2017 -S$28.68 Million19.56%
2016 -S$23.99 Million55.21%
2015 -S$15.46 Million142.32%
2014 -S$6.38 Million-137.39%
2013 S$17.05 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
S$7.33 B-26,387.74%๐Ÿ‡บ๐Ÿ‡ธ USA